Arrhythmias & electrophysiology

Coherent mapping of atrial tachycardias in patients with congenital heart disease

EuropacePublished Retrospective cohort study

Authors' conclusion

Mapping of AT in patients with CHD using the PENTARAY™ mapping catheter and the CM algorithm led to excellent acute success. All ATs were possible to map and no complications related to the PENTARAY™ mapping catheter were observed.

Study context

Population
Patients with congenital heart disease undergoing ablation of atrial tachycardiaprocedures in 42 patients
Participants
54 ablation procedures
Exposure
Coherent mapping vs mapping without coherent mapping (CM) for AT ablation
  • Coherencen = 27
  • non-Coherencen = 27reference
Outcome
Acute success
Methodological detailshistorical control group
  • Historical control group

Main finding

As reported in the abstract

P = 0.01

Observational data: associations, not effects.

Further findings

OutcomeP value
AT recurrence · median 26 (12-45) monthsNo differenceP = 0.29
AT recurrence — AT recurred (overall)
28/54
AT recurrence — Re-ablation needed
15

Procedure duration and fluoroscopy time (all procedures)

Median procedure duration, min (IQR)
180 (120-214)
Median fluoroscopy time, min (IQR)
10 (5.2-14)

Safety

Minor complications (overall)

Minor complications
3 (5.5%)

Original publication

Coherent mapping of atrial tachycardias in patients with congenital heart disease. Europace. Published 16 February 2023. doi:10.1093/europace/euad024

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.